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ABSTRACT 
The development of biomaterials for scaffold and tissue engineering are in great 
advancement. Porous materials like bioceramic and polymer components for supporting 
bone tissue and cell growth are becoming an area of great interest in research [1]. 
Traditionally, biodegradable polymers have been used as scaffold material [2]. However, 
these materials are weak and non-osteoconductive. Polymer-based composite scaffolds 
containing bioceramics was then used to substitute the material. Thus, it is strongly 
believed that the bioceramic phase delivers the bioactivity and improves scaffolds 
strength. In addition to that, recently the engineering of biomaterial focused on the kind 
of material which can mimic both the mechanical and biological properties of real bone 
tissue matrix and this method known as biomimetic [3]. Other than that, there are also 
other recent challenges where scientists are also looking for biomaterials which can 
support the development of new blood vessels and large tissue formation. This paper was 
intended to demonstrate an overview of the current and potentially future development of 
composite bioceramic based scaffolds for bone tissue engineering. 
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INTRODUCTION 
The development of biomaterials for scaffold and tissue engineering are in great 
advancement. Porous materials like bioceramic and polymer components for supporting 
bone tissue and cell growth are becoming an area of great interest in research [1]. 
Previously materials were designed to be bioinert just to replace defected and injured 
hard tissue. However, with the development of technology the purpose of materials 
design nowadays has been shifted to be bioactive which combines with biological 
molecules or cells and stimulate tissues [1,4]. 
An ideal scaffold for bone regeneration requires many criteria. The basic criterion of the 
scaffold material is that the materials should preferably be both osteoinductive and 
osteoconductive. Osteoinductive is the ability to promote the new osteoblast generation 
from the mother cell. Osteoconductive is to encourage bone growth and support the 
ingrowths of surrounding bone. They must also be osseointegration which means can 
integrate into surrounding bone [1]. 
The new challenge today is to design scaffolds which can mimic the composition and 
properties of the organ which they aim to replace such as bone which has a complicated 
hierarchical structure. Another challenge is to design scaffolds that can stimulate and 
facilitate full bone regeneration in three dimensions and then degrading simultaneously 
with the growth of the new tissue. The scaffolds must also mechanically capable to 
support the work loading during the forming of the new tissue until the new tissue bond is 
strong enough to accept the loading [5]. 
The most important consideration today is to determine the size of porosity of the 
scaffold so that it can assure the bone vascularization. This is because if the blood vessels 
does not reach the scaffold, the new formed tissues will fail to function. To date, the 
suggested porosity for successful bone ingrowths and sufficient oxygenation are 100 um. 
Other than that, scaffolds material should also be compatible with the bonding 
environment and its requirement [1,5]. 
There are several materials which have been designed for implantation that are therefore 
candidate materials for scaffolds development. In general, they consist of either synthetic 
polymers or bioactive materials, including bioactive glasses, bioactive glass-ceramics, 
bioactive calcium phosphate ceramics and bioactive composites and coatings. However 
to date there are still no such material that can fulfill all the criteria. Here, we present 
some of the materials which have been used in the tissue engineering and scaffolding for 
the past four decades. 
TYPE OF SCAFFOLD MATERIALS 
Polymers 
Previously, biological polymers like collagen and hyaluronic acid and synthetic polymers 
like polyfumarates, polylactic acid (PLA), polyglycolic acid (PGA), copolymers of PLA 
and PGA (PLGA), and polycaprolactone has been used as bone implant. These polymers 
can attach well with cells and promote chemotactic responses. They have been accepted 
by medical-profession-accepted and the US Food and Drug Administration (FDA) as the 
suitable material for tissue substitute [1]. However the strength of these materials are very 
weak and will reduce further if porosity is applied to them. Furthermore the materials are 
also non-osteoconductive [2]. 
Recently bioactive bioceramics like tricalcium phosphate, Hydroxyapatite (HA), 
bioactive glasses, and their combinations have broadly been used for bone tissue 
engineering applications. These bioactive bioceramics is potentially use for bone tissue 
engineering and the development of scaffolds. 
Bioactive Glass 
One of the bioactive glass which often used to repair bone defects is synthetic 
hydroxyapatite (sHA,Caio(P04)60H2) since its mineral, carbonated hydroxyapatite has 
the similarity with mineral of the natural bone. The bioactive glass also proven to be 
bioactive and osteoconductive. The weakness of this material is that it resorbtion rate is 
very slow. We can increase the resorbtion rate by adding silicon or carbonate substituted 
apatites. However the increasing rate is not much different with the previous. Thus, the 
bioactive glass can only be used as an implant of the damage bone but not for bone 
regeneration scaffold [6]. 
Bioglass®. 
In 1971, Professor Larry Hench launched the alternative bioactive glass, the Bioglass® 
with the composition Na20-CaO-P 2 0 5 -Si0 2 system with B 2 0 3 and CaF 2 additions. This 
bioglass formed a strong supporter for the bone bonding. [7] The advantages of this 
material are they are bioactive. In vitro tests showed that they form a carbonated apatite 
layer on their surface which is chemically and structurally similar to the mineral phase in 
bone thus enhancing the bonding of the bone [8]. In addition, they are osteoinductive 
since they can generate new bone to grow when they dissolve in the body. They 
discharge critical concentrations of active ions and inspire the genes with osteogenic cells 
[9]. However, this material resolve on sintering and form a glass-ceramic. Due to that, 
Bioglass cannot be made into a scaffold. [10] 
A-W glass-ceramic 
Kokubo et al. has developed a new glass-ceramic, Apatite-wollastonite (A-W) glass-
ceramic in 1982. It has the highest bending strength, fracture toughness and Young's 
modulus among bioactive glass and glass ceramics. This criteria fulfills some major 
compression load bearing applications like vertebral prostheses and iliac crest 
replacement. It combines high bioactivity with suitable mechanical properties. [11] 
Calcium Phosphate 
Levitt et al. have discovered that calcium phosphate is a mineral component in the natural 
bone in 1969 [12]. Then, several researches were conducted on synthetic calcium 
phosphate ceramics, Hydroxyapatite (HA) between 1980 and 1990. Hence, it became the 
most popular synthetic ceramic for implantation. Calcium phosphates are now used for a 
variety of different applications covering all part of the bone such as spinal fusion, 
restoration of craniomaxillofacial, bone defects and breakage healing, substitution of total 
joint and revision surgery [4]. Calcium phosphate implants especially hydroxyapatite, 
also has been used in the form of coatings on metallic implants, as fillers in polymer 
matrices, as self setting bone cements, as granules or as larger, shaped structures. 
In 1980s de Groot et al introduced the hip prostheses femoral stems which was plasma 
sprayed with hydroxyapatite [13]. The plasma-sprayed stems were first implanted in 
patients by Furlong and Osborn [14]. This Hydroxy apatite-coated implant was clinically 
proved to have much longer life times after implantation than uncoated devices. It was 
also found that, this implantation is better on young patients [15]. 
The prospect of calcium phosphate as a filler in polymer-matrix composites was done by 
Dr. Bonfield's research group. The material was successfully developed as middle ear 
implants and marketed under the name HAP EX® [16]. The advantage of using this 
polymer-ceramic composites is that we can set desirable mechanical properties such as 
the strength via the ceramic phase and the toughness via the polymer phase. Another 
advantage of the materials is that they can easily can be shaped due to their softness and 
flexibility [17]. 
The potential of calcium phosphate for in situ molding and instill bone cements was also 
being discussed in 1980s. These bone cements is formulated based on different 
combinations of calcium compounds like tricalcium phosphate and dicalcium phosphate. 
However the final output is always calcium deficient hydroxyapatite [18, 19]. 
The development of chemically synthesized materials with reproducible structures and 
chemical composition has become important to replace natural bone for bone grafting. 
This is due to the limited availability of the natural bone. Bonfield, Best and co-workers 
has studied on the development of silicate-substituted hydroxyapatites (Si-HA) as the 
potential bone graft materials [20]. Proteins and cells is included into the HA implant in 
order to improve its integration with bone. In vivo studies, comparing the rates of bone 
apposition to HA and Si-HA ceramic implants, demonstrated a significant increase in 
amount of bone apposition and organization to around silicon substituted HA (Si-HA) 
implants. 
Bioctive Composites and Coatings 
Bioglasses, glass-ceramics and calcium phosphate ceramics is said to have outstanding 
bioactivity since the bond from these materials is generally stronger or equal to the host 
bone. The drawback of these bioactive ceramics is that they are less elastic and have 
weaker fracture toughness compared to bone. Hence, they are not biomechanically 
compatible for load bearing applications. In order to overcome this problem, structural 
tailoring of bioactive composites or coatings is applied [21]. 
A bioactive composite is a mixing of the polymer toughness and the inorganic strength to 
produce the kind of material which can mimic both the mechanical and biological 
properties of real bone tissue matrix and this method known as biomimetic. The 
composite also neutralizes the acidity of the polymer with alkalinity of the inorganic stuff 
[3]. Other than that, there are also other recent challenges where scientists are also 
looking for strong porosity biomaterials which can support the development of new blood 
vessels and large tissue formation. 
Applying these materials as a coating on a mechanically tough substrate is the other 
method to overcome the load-bearing applications weakness. The bioactive coating 
materials have the excellent bioactivity of the bioactive glasses or ceramics, as well as the 
advantageous mechanical properties of metals or alumina. The bone-bonding capacity of 
these coating may help provide cementless fixation of orthopedic prostheses, especially 
in short term stabilization of the implants. But in long term implantation, the bioactive 
coating materials have deficiencies with respect to reliability of the coating/implant 
interface. 
Sol-gel Glasses 
Sol-gel glasses are derived from the early bioactive glasses. The sol-gel route can 
generate high purity glasses, which are more homogeneous than the early bioactive 
glasses. They have the strength which is similar to cancellous bone. They demonstrate 
higher surface area and porosity than the dense melt-derived glasses. They fulfill 
requirement of the osteogenic properties. Furthermore, their nanoporosity elements serve 
a controlled degradation and provide area for the cell to attach and the adsorption of the 
protein. In addition, the porosity is suitable for vascularised bone ingrowths. 
The sol-gel can be composed with functionalised biodegradable polymers to produce 
inorganic-organic hybrid nanoscale composites. Hence, we can have the material which 
blend the bone bonding and bioactive ion release with toughness and controlled 
degradation. However, the chemistry and materials processing routes are complex, so the 
ideal materials are yet to be developed. 
DISCUSSION AND CONCLUSSION 
We have discussed some dramatic improvement in the engineering of biomaterial for 
medical usage especially in the numerous bioceramics being used in clinical application 
and also the quality of bone engineering they have delivered. However, the design criteria 
for an ideal scaffold for bone regeneration have not been fulfilled sufficiently. There is 
still potential development to be made in this field. Scientists and engineers are still 
required to research the ideal material that combines all the criteria of an excellent 
scaffold and at the same time need to determine the matrix of the scaffold. From our 
finding, we can list down the excellent criteria as follows: 
1. Porosity size supports bone vascularization, bone ingrowths and sufficient 
oxygenation and degrading simultaneously with the growth of the new tissue 
2. Mimic the composition and properties of real bone 
3. Have the osteoinductive, osteoconductive and bioactive quality 
4. Have the mechanical strength to support the work loading during the bone bonding. 
Finally, the advancement of the scaffolding material technology is drifting and we hope 
to see forward more new composition materials which potentially could demonstrate the 
quality of the real bone in the future. 
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